Abstract-In developing implantable tissues based on cellular remodeling of a fibrin scaffold, a key indicator of success is high collagen content. Cellular collagen synthesis is stimulated by cyclic stretching but is limited by cellular adaptation. Adaptation is mediated by deactivation of extracellular signal-regulated kinase (ERK); therefore inhibition of ERK deactivation should improve mechanically stimulated collagen production and accelerate the development of strong engineered tissues. The hypothesis of this study is that p38 mitogen activated protein kinase (p38) activation by stretching limits ERK activation and that chemical inhibition of p38 a/c isoforms with SB203580 will increase stretching-induced ERK activation and collagen production. Both p38 and ERK were activated by 15 min of stretching but only p38 remained active after 1 h. After an effective dose of inhibitor was identified using cell monolayers, 5 lM SB203580 was found to increase ERK activation by two-fold in cyclically stretched fibrin-based tissue constructs. When 5 lM SB203580 was added to the culture medium of constructs exposed to 3 weeks of incremental amplitude cyclic stretch, 2.6 fold higher stretching-induced total collagen was obtained. In conclusion, SB203580 circumvents adaptation to stretching induced collagen production and may be useful in engineering tissues where mechanical strength is a priority.
INTRODUCTION
Fibrin is an attractive biomaterial for a variety of engineered tissues, including arteries, valves, and myocardium, because it is fully degradable, can be derived from the patient's own protein and cells, and can be cast in the desired geometry. Fibrin scaffolds also align in response to cell traction forces, resulting in the alignment of cell-produced extracellular matrix such as type I collagen. 2, 9, 10, 19, 31 Collagen content is correlated with the ultimate tensile strength and modulus of fibrin-based tissue constructs and is therefore a strong indicator of the tissue's durability in response to relevant mechanical forces (e.g., pulse pressure for the case of engineered vessels). 25 A variety of stimuli have been used to improve the collagen content of fibrin-based constructs, including changing the initial cell content, 10 adding growth factors to the medium, 25 and applying cyclic stretching using a bioreactor. 38 Current attempts at optimization of mechanicallyinduced collagen production have been thwarted by the phenomenon of adaptation. Adaptation can be mediated by receptor internalization and/or degradation, as is seen with the epidermal growth factor receptor, 7 negative feedback via protein inhibitors, as is the case for Smad7 and TGF-b signaling, 24, 36 or via transcriptional repression, as in the circadian clock. 12 Strategies of incremental and intermittent cyclic stretching have increased collagen production in response to mechanical stimulation 28, 32, 38 but have failed to address the fundamental problem of adaptation by pharmacologically targeting the signaling pathway(s) responsible for the effect. The mitogen-activated protein kinase (MAPK) extracellular signal-regulated kinase (ERK) has been previously implicated as a key signaling species involved in adaptation. 38 ERK mediates type I collagen expression in response to stimulation by mechanical force 13, 16 as well as in response to treatment with TGF-b, 23 ,29 the cytokines IL-4 and IL-13, 3 endothelin-I, 30 and angiotensin II. 39, 45 Another MAPK activated in response to stretching, p38, has an antagonistic effect on ERK activation. 4, 14, 15, 26, 41 In the context of engineered connective tissue, TGF-b-induced p38 signaling limits stretching-induced collagen production 37 ; however, the contribution of p38 MAPK signaling to collagen expression in the absence of exogenous TGFb has been insufficiently explored.
The hypothesis of this study was that chemical inhibition of p38 during an incremental amplitude cyclic stretching regime would lead to increased collagen content in the final tissue construct. To address this hypothesis, the stretching-activated cellular response was monitored from the early step of ERK activation to the final collagen content.
METHODS

Cell Culture
Neonatal human dermal fibroblasts (Invitrogen) were maintained in DMEM/F12 supplemented with 10% fetal bovine serum (Hyclone), 100 units/mL penicillin, and 100 lg/mL streptomycin. Cells were passaged near 100% confluence and harvested for use from passages 7-9. For cell stretching experiments, cells were plated on fibronectin-coated silicone membranes in 24-well high throughput BioFlex plates (FlexCell International), and were stretched once they reached confluence.
Tissue Construct Fabrication and Culture
A cell-seeded fibrin gel was molded by mixing cells suspended in DMEM into a solution of bovine fibrinogen (Sigma) in 20 mM HEPES-buffered saline. A mixture of bovine thrombin (Sigma) and CaCl 2 in DMEM was then added to the suspension. All components were on ice prior to mixing. Final concentrations were 6.7 mg/mL fibrinogen, 0.8 units/ml thrombin, 5 mM CaCl 2 , and 500,000 cells/mL. Suspensions were mixed well by trituration and pipetted (1.5 mL/well) into circular tissue-train 6-well plates (FlexCell International), making sure to incorporate the gel into the circumferential foam mesh. The initial gelation was performed for 30 min in a tissue culture incubator, then 4 mL of culture medium was added to each well. Subsequent media changes used 3 mL/well. Constructs were maintained in static culture for 1 week before stretching.
Cyclic Stretch Conditioning of Tissue Constructs
Prior to stretching experiments, all constructs were changed to media supplemented with insulin (2 lg/mL, Sigma) and ascorbic acid (50 lg/mL, Sigma); SB203580 (5 lM, Sigma) was also added to the indicated samples. Cyclic stretching was performed by placing the plates on the FX-5000 Tension System (FlexCell International), using 25 mm circular loading posts and applying a cyclic stretch regime (duty cycle of 15% and frequency of 0.5 Hz). The stretching amplitude was either held constant, as indicated in the figure captions, or varied from a set point of 2.5-9.5% during the long-term studies; a 1% increment in amplitude and fresh SB203580 was added during each media change (every 48-72 h).
Protein Extraction
At harvest, each construct was rinsed with cold phosphate buffered saline (PBS) and frozen at À80°C until lysis. The tissue was then disrupted by sonication in ice-cold lysis buffer [25 mM NaF, 0.5% Nonidet P-40, 1 mM EDTA, HALT phosphatase inhibitor cocktail (Pierce), 1 lg/mL aprotinin, pepstatin, and leupeptin (Sigma) in PBS]. The soluble lysate was isolated by centrifugation, and the protein concentration was determined by bicinchoninic assay (Pierce). For cyclically stretched monolayers, cells in each well of the 24-well plate were lysed in 100 lL of SDS-PAGE sample buffer.
Western Blot
20 lg of total protein/well (or 5 lL of cell lysate from monolayers/well) was separated by reducing SDS-PAGE, transferred to a nitrocellulose membrane (Whatman), and immunoblotted for beta-actin (Sigma #A5441), phosphorylated ERK (#9101), total ERK (#9102), phosphorylated p38 (#9211), or total p38 (#9212, all ERK and p38 primary antibodies were from Cell Signaling Technologies). Briefly, the blots were blocked for 1 h (block was 5% dry milk, 0. and PBS, and developed by enhanced chemiluminescence. Films were digitized using ScanJet G4050 set to transparency mode (Hewlett Packard) and quantified for band density using ImageJ (NIH). On a given blot, normalization was performed by first dividing the phosphoprotein intensity by the total protein intensity (e.g., pERK/tERK) and then dividing all sample data by the untreated static control value. Static values were therefore always equal to 1 (dashed line in figures).
Quantification of Collagen and Cellularity
Collagen content was measured with the hydroxyproline assay of Stegemann and Stalder, 35 with collagen per sample calculated using a conversion factor of 7.46 mg of collagen per mg of 4-hydroxyproline. 6 Values were then normalized to the drug-matched static controls. Total protein was measured with the modified ninhydrin assay. 19, 34 Cellularity was measured with a modified Hoechst assay. 43 
Statistical Analysis
Unless otherwise noted, all numerical data indicates the mean ± standard error with n = 3 or greater in each sample group. Significance was assigned by Student's t test between paired sample groups, and p < 0.05 was reported as significant. With the exception of the cellularity data and any comparisons marked ''n.s.'', all values for cyclically stretched samples were significantly higher than paired static controls.
RESULTS
Cyclic Stretching Induces Activation of Both p38 and ERK MAPK in Fibrin-Based Tissue Constructs
Fibrin-based tissue constructs were fabricated in 6-well plates where the fibrin was physically anchored by a foam mesh around the circumference of each well. After 1 week of static incubation, the FX-5000 Tension System (FlexCell International) was used to expose the cells embedded within the constructs to constant amplitude cyclic stretching. 15 min of stretching induced both p38 and ERK activation in the tissue constructs, relative to static controls (Fig. 1) . After 1 h of stretching, p38 activation remained elevated while ERK activation was reduced to static control levels.
Stretching-Induced ERK Activation is Enhanced with p38 a/c Inhibition
Since p38 is activated by cyclic stretching for the entire duration of ERK activation (Fig. 1 ) and negatively regulates ERK signaling, 4, 14, 15, 26, 41 the effect of the p38 a/c antagonist SB203580 on stretchinginduced ERK activation was evaluated. Cells grown on pronectin-coated silicone membranes (FlexCell International) were treated with a range of SB203580 concentrations from 0.05 to 5 lM prior to exposure to 15 min of cyclic stretching. This membrane coating was chosen to mimic the fibronectin-rich environment of the remodeled three-dimensional fibrin scaffold. While the vehicle control had no effect on stretchinginduced ERK activation, a 5 lM concentration of SB203580 showed a significant benefit (Figs. 2a and  2b) .
From these data, and consistent with other published work, 27,37 5 lM SB203580 was selected as a suitable concentration for subsequent studies using fibrin-based tissue constructs. 15 min of cyclic stretching induced ERK activation by cells in this 3D system; pretreatment with 5 lM SB203580 augmented the stretching-induced ERK activation by 207 ± 18% (Fig. 2c) .
p38 a/c Inhibition Increases the Final Collagen Content of Cyclically Stretched Fibrin-Based Tissue Constructs and Offsets a Stretching-Induced Decrease in Cell Proliferation
Following on previously published studies that used periodic strain incrementation to combat adaptation, 38 an incremental amplitude cyclic stretch regime was employed for long-term stretching of tissue constructs. At each increment in strain amplitude, stretchinginduced signaling should re-occur 33 ; therefore, the culture medium was changed prior to each incrementation step with a fresh 5 lM dose of SB203580. After an eight step incrementation regime from 2.5 to 9.5% strain amplitude over 3 weeks, the final collagen FIGURE 1. Cyclic stretching induces activation of both p38 and ERK MAPK in fibrin-based tissue constructs. Fibrinbased tissue constructs were exposed to the indicated duration of 8% amplitude cyclic stretch and then analyzed by Western Blot. A representative blot for phosphorylated (p-) and total (t-) ERK, p-p38, t-p38, and beta-actin (as a loading control) is shown.
content of the tissue constructs was determined. Incremental amplitude stretching led to an increase in collagen content over static controls as expected (Fig. 3a) . Notably, 5 lM SB203580 augmented the stretching-induced collagen content 2.6 fold higher than that obtainable by stretching alone (1.5 ± 0.13 fold increase in collagen over drug-treated static controls compared to a 1.2 ± 0.02 fold increase in collagen over static with no drug). In the absence of stretching, 5 lM SB203580 had no effect on collagen content (Fig. 3b) . Total protein content was constant regardless of stretching or drug treatment (Fig. 3c) .
Inhibition of p38 with SB203580 can promote the proliferation of differentiated cells. 8 Therefore, we characterized the effect of stretching and SB203580 on the final cellularity of our constructs (Fig. 3d) . Stretching alone decreased the final cellularity regardless of drug treatment; since the final cellularity was greater than at fabrication (0.75 million cells), we consider this a stretching-mediated inhibition of proliferation. SB203580 treatment of static constructs had no effect on cellularity (4.32 ± 0.18 9 10 6 cells vs. 4.64 ± 0.11 9 10 6 cells for untreated vs. 5 lM SB, p > 0.2). However, SB treatment appeared to ameliorate the stretching-induced decrease in proliferation we typically observe, with an increase in cellularity with drug treatment when comparing the stretching groups (2.54 ± 0.19 9 10 6 cells vs. 3.45 ± 0.20 9 10 6 cells for untreated vs. 5 lM SB, p < 0.01). Stated differently, the stretching-induced decrease in cellularity was less in the presence of SB (41 ± 4% vs. 26 ± 4% for untreated vs. 5 lM SB, p < 0.05).
DISCUSSION
To produce a collagen-rich tissue from the cellmediated remodeling of a fibrin gel, it is essential to consider the cell's biomechanical context. Stretching activates MAPK signaling downstream of both stretch-sensitive ion channels 17 and focal adhesion kinase 20 ; also, changes in stiffness can dynamically alter fibroblast phenotype. 40 Notably, the current study shows that deactivation kinetics can vary by MAPK type; while both ERK and p38 are strongly activated 15 min after the onset of stretching, only p38 remains activated after 1 h. Since p38 signaling has known antagonistic effects towards ERK activity, this suggests that the co-activation of ERK and p38 in response to stretching acts to dampen the ERK response. Uncontrolled ERK signaling can be dangerous to the organism; in many cancers Ras/MAPK signaling is constitutively activated leading to the proliferation hallmark of tumor cells. To this end ERK signaling is highly regulated; in addition to p38, Akt signaling 18 and the activity of dephosphorylases such as DUSP6 22 can deactivate the ERK signal. In the context of tissue engineering, however, cyclic stretching is a common and convenient strategy to promote ERK-mediated collagen production so the negative p38 feedback is problematic.
Application of SB203580, which inhibits the a and c isoforms of p38, 1 increased ERK activation in response to stretching (Fig. 2) . It is unlikely that the positive effects of SB203580 would have been identified in a typical drug screen, since the benefits were limited to the context of stretching. High-throughput stretching systems are emerging that could be useful for identifying additional targets. 21, 44 SB203580 has a known off-target effect as an activator of Raf protein kinase and downstream ERK signaling at high doses 11 ; however, at the 5 lM dose used in this study it did not activate ERK in static culture. An alternative explanation for the positive effects of SB203580 involves the antibiotic streptomycin, which was present in our culture media. Streptomycin can block stretch-sensitive ion channels 5 ; potentially, SB203580 acts to relieve the streptomycin block, enabling stronger stretching-induced signaling. To address this, we measured p38 and ERK activation in cell monolayers after 15 min of stretching in the presence and absence of streptomycin. We found no difference in MAPK activation due to the antibiotic (data not shown).
During 3 weeks of incremental amplitude cyclic stretching, 5 lM SB203580 supplementation in the culture medium provided a significant benefit for stretching-induced collagen content. This was remarkable for two reasons. First, the drug enhanced collagen production beyond that obtained with an eight-step incremental amplitude cyclic stretching regime; incremental and intermittent stretching regimes are the current best practices for increasing collagen production. 28, 38 Second, SB203580 has been reported to have a half life on the order of 4 h, 42 which is much smaller than the 2-3 day intervals between drug replenishment. The half-life of the drug is long enough to inhibit p38 during the first few hours of stretching, which appears to be the critical period for stimulating cellular collagen production.
An additional benefit of augmenting stretchinginduced ERK signaling in the tissue engineering context is increased cellular proliferation. Since the sole source of collagen in remodeled fibrin-based tissue constructs is the entrapped cells, cell proliferation is desirable. Stretching inhibits proliferation, and therefore can have a negative impact on total matrix production. By prolonging ERK activation with FIGURE 3. p38 a/c inhibition increases the final collagen content of cyclically stretched fibrin-based tissue constructs and offsets a stretching-induced decrease in cell proliferation. Fibrin-based tissue constructs were exposed to 3 weeks of incremental amplitude cyclic stretch (filled bars) 65 lM SB203580 (SB) or were maintained in static culture (empty bars). (a, b) Total collagen was determined by the biochemical quantification of hydroxyproline content and normalized to the collagen content of drugmatched static controls. There was no change in the collagen content of static constructs with drug treatment, but stretchinginduced collagen was increased 2.6 fold further with SB treatment. * = p < 0.05 with Student's t test (n = 19 per group). (c) Total protein content of constructs was unchanged with stretching or SB treatment. (d) Stretching led to a decrease in cellularity at harvest, as measured by Hoechst assay. SB treatment partially offset the stretching effect but did not prevent it entirely. * = p < 0.05 with Student's t test (n = 3 per group). SB203580, we achieved higher final cellularity in our stretched tissue constructs. This benefit on proliferation was limited to stretched constructs since the drug had no effect on the cellularity of static constructs. The likely mechanism for beneficial SB203580 activity is thus a combination of cellular proliferation and collagen synthesis downstream of prolonged ERK activation (Fig. 4) .
CONCLUSIONS
Cyclic stretching activates both ERK and p38 MAPK signaling in fibrin-based tissue constructs. By inhibiting p38 a/c in the context of cyclic stretching, higher ERK activation is achieved, leading to the production of a tissue starting from a fibrin gel with increased cellularity and superior collagen content. 
